| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8446589 | European Journal of Cancer | 2012 | 10 Pages |
Abstract
This study suggests that galectin-3 is a marker of progression in melanocytic lesions and a novel prognostic marker in primary melanoma.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Ewan R. Brown, Tamasin Doig, Niall Anderson, Thomas Brenn, Val Doherty, Yan Xu, John M.S. Bartlett, John F. Smyth, David W. Melton,